Read More Pharma Industry News MeiraGTx signs $475m ophthalmology gene therapy collaboration with Eli Lilly MeiraGTx Holdings plc signed a USD 475 million gene therapy deal with Eli Lilly and Company to develop AAV-AIPL1 and apply riboswitch tech in ophthalmology. byVenkateshNovember 10, 2025